Rituximab-induced hypersensitivity pneumonitis in a kidney transplant patient

Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been associated with delayed pulmonary toxicity. In patients receiving RTX, hypersensitivity pneumonitis, although rare, should be considered in the appropriate clinical and radiographic setting. The authors present a case of hyper...

Full description

Bibliographic Details
Main Author: Silva,Natália (author)
Other Authors: Ribeiro,Catarina Isabel (author), Almeida,Manuela (author), Malheiro,Jorge (author), Pedroso,Sofia (author), Martins,Maria La Salete (author), Dias,Leonídio (author), Henriques,António Castro (author), Cabrita,António (author)
Format: report
Language:eng
Published: 2020
Subjects:
Drug-induced lung disease
hypersensitivity pneumonitis
kidney transplant
rituximab
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692020000300010
Country:Portugal
Oai:oai:scielo:S0872-01692020000300010
Description
Summary:Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that has been associated with delayed pulmonary toxicity. In patients receiving RTX, hypersensitivity pneumonitis, although rare, should be considered in the appropriate clinical and radiographic setting. The authors present a case of hypersensitivity pneumonitis associated with a single dose of RTX treatment in a kidney transplanted patient with acute antibody-mediated rejection.

Similar Items